Quest Opens State-of-the-Art Megalab

Quest Diagnostics has unveiled a new, massive state-of-the-art laboratory in Massachusetts, which the company says will help modernize health care delivery. The 200,000-square-foot facility is … [Read more...]

LabCorp Acquires Covance in $5.6 Billion Transaction

LabCorp has thrown its hat into the pharmaceutical testing arena in a huge way: It is acquiring biopharma contract testing giant Covance in the biggest transaction ever in the laboratory … [Read more...]

Industry Buzz: PDI Acquires RedPath Integrated Pathology

New Jersey-based PDI has acquired RedPath Integrated Pathology, a Pittsburgh-based firm that specializes in developing tests that focus on diagnosing and managing gastrointestinal cancers. The deal … [Read more...]

Inside the Lab Industry: Labs’ Ability to Obtain Payer Contracts Limited, Observers Say

Gregory Solak expects to have an answer soon. The vice president for laboratory services for Kaleida Health has helped to painstakingly craft a relationship between the upstate New York hospital … [Read more...]

Foundation Medicine Strikes Deal for Testing in China

Foundation Medicine has struck a deal with an overseas firm to offer some of its assays in China. Under the terms of the deal reached with Shanghai-based WuXi PharmaTech Inc., the Cambridge, … [Read more...]

Inside the Lab Industry: Laboratory M&A: Volume of Deals Mostly Unchanged From a Year Ago

As 2014 comes to a close, the volume of mergers and acquisitions in the laboratory sector during the calendar year is hewing close to what transacted in 2013, although there is more movement in the … [Read more...]

LabCorp Expands DNA Testing With Acquisition Of Bode Technology

The DNA of LabCorp has changed significantly over the last year as it has made some huge purchases in order to diversify. And as a result of its latest wade deeper into the lab sector gene pool, it … [Read more...]

A 2015 Preview for the Laboratory Sector

The year 2014 was a challenging one for laboratories. They continued to confront cuts in reimbursement even as the Affordable Care Act brought millions of more Americans into the insurance fold for … [Read more...]

Venture Capital and Laboratories: A Lingering Question Mark

Despite the vastness of the health care industry, the laboratory sector is one business branch with minimal leverage. Despite its ubiquity - what patient hasn't undergone a lab test? - it still only … [Read more...]

Through Deals and an Executive Revamp, Aurora Diagnostics Strains Toward the Black

Debt-laden Aurora Diagnostics has all but revamped its executive ranks and engaged in several deals in the past few months that has refocused the Florida-based laboratory on pathology and … [Read more...]